Condition
Mesothelioma
Estimated Enrollment: 537
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double Blind (masked roles unspecified)|Primary Purpose: Treatment
Study ID Numbers: 1199.93|2012-005201-48
Study First Received: July 22, 2013
Last Updated: April 18, 2017
Estimated Primary Completion Date: October 30, 2019
Primary Outcome Measures:
Progression free survival measured from the time of randomisation to the time of disease progression or death of any cause, whichever occurs earlier|Overall survival measured from the time of randomisation to the time of death of any cause|Objective response according to modified RECIST analysed by objective response rate|Disease control according to modified RECIST analysed by disease control rate
Sponsors and Collaborators:
Boehringer Ingelheim
Website Link: https://ClinicalTrials.gov/show/NCT01907100
